Oppenheimer Initiates Coverage On Astrana Health with Outperform Rating, Announces Price Target of $53
Benzinga Newsdesk 1 month ago
Analyst RatingsNewsInitiationPrice Target
Oppenheimer analyst Michael Wiederhorn initiates coverage on Astrana Health (NASDAQ:ASTH) with a Outperform rating and announces Price Target of $53.
Oppenheimer analyst Michael Wiederhorn initiates coverage on Astrana Health (NASDAQ:ASTH) with a Outperform rating and announces Price Target of $53.